TLP Group’s Zimmer Biomet ZBH Stock Holding History

TLP Group’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-12	Closed	-$1K	–	654
2017 Q4	$1K	Sell	12 -22	-65%	-$2.49K	﹤0.01%	569
2017 Q3	$4K	Sell	34 -1,973	-98%	-$228K	﹤0.01%	470
2017 Q2	$250K	Buy	+2,007	New	+$238K	0.23%	135
2017 Q1	–	Sell	-1,870	Closed	-$187K	–	452
2016 Q4	$187K	Buy	1,870 +828	+79%	+$88.7K	0.19%	152
2016 Q3	$132K	Buy	+1,042	New	+$129K	0.14%	111
2016 Q2	–	Sell	-206	Closed	-$21K	–	427
2016 Q1	$21K	Buy	+206	New	+$19.9K	0.01%	270

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TLP Group's ZBH Position: Q1 2018 in Review

TLP Group sold out of Zimmer Biomet (ZBH) in Q1 2018, closing a stake of 12 shares — an estimated $1K sold.

TLP Group first reported a position in ZBH in Q1 2016 and held it in 6 quarters. The position peaked at $250K in Q2 2017. 875 funds tracked by Wall St. Rank hold ZBH as of Q1 2018.

TLP Group reported no remaining Zimmer Biomet position as of Q1 2018 after selling out during the quarter.
TLP Group sold 12 Zimmer Biomet shares in Q1 2018, an estimated $1K.
TLP Group first reported a position in Zimmer Biomet in Q1 2016 and held it in 6 quarters.
TLP Group's Zimmer Biomet position peaked at $250K in Q2 2017.
875 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2018.

Based on TLP Group's 13F filing for Q1 2018, filed 16 May 2018.